Skip to content

Pandemic Acceptance and Commitment Therapy (Pan-ACT): Telehealth Delivery With Older Veterans

Pandemic Acceptance and Commitment Therapy (Pan-ACT): Feasibility and Acceptability of Telehealth Delivery With Older Veterans

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05433662
Acronym
Pan-ACT
Enrollment
24
Registered
2022-06-27
Start date
2022-12-20
Completion date
2025-01-23
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychological Stress

Keywords

Older adult, acceptance and commitment therapy, telehealth, pandemic

Brief summary

Older adults have been disproportionately impacted and distressed by the novel coronavirus (COVID-19) pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in close proximity to other people. These fears and avoidant behaviors will have lasting effects if not treated with effective, safe, and convenient psychological interventions. This study will evaluate the acceptability and feasibility of delivering a small group intervention, called Acceptance and Commitment Therapy (ACT), through a telehealth modality to Veterans ages 60 and older who are experiencing pandemic-related emotional and physical distress. ACT helps decrease emotional suffering, improve well-being and promote positive behavior change by increasing one's psychological flexibility through the practice of mindfulness, acceptance, and values-based behaviors. The knowledge gained from this study will be used to better tailor the invention to meet the needs of older Veterans in an era of post-pandemic recovery.

Detailed description

Significance: Accounting for over 80% of COVID-19 related deaths in the United States, adults ages 60 and older have been disproportionately impacted by this pandemic more than any other age group. As a result, they may bear a heavy psychological burden in the months and years to come. Older adults have been labeled "vulnerable" to COVID-19 and strongly encouraged to adhere to "social distancing." This prevention measure is meant to mitigate the spread of the virus but has increased older adults' risk of social isolation and loneliness, which are two known correlates of increased morbidity and mortality in late life. Pandemic-related restrictions have decreased older adults' life-space mobility and negatively affected their physical and nutritional well-being, impairing their quality of life and potentially increasing their vulnerability to poorer outcomes if exposed to COVID-19. Research has documented a plethora of pandemic-related stressors that are common among older adults (e.g., fear of infection, loss of loved ones, financial repercussions) and the culminating psychological impact. Telehealth-adapted evidence-based psychological interventions are needed to address the psychosocial and physical toll of the pandemic among older Veterans. Acceptance and Commitment Therapy (ACT) decreases emotional suffering, improves well-being, promotes and supports healthy behavior changes, and treats a wide range of diagnoses by increasing psychological flexibility through mindfulness, acceptance, and values-based behaviors. Higher psychological flexibility has been associated with pandemic-related coping and well-being. Randomized studies of ACT with older adults are few but promising, and most research studies with this population have used a group format. While research on telehealth delivery of ACT for older adults is limited, preliminary results indicate it is feasible and as effective as ACT delivered in person. Specific Aim: The proposed study will pilot a 10-session telehealth Pandemic ACT group intervention (i.e., Pan-ACT group) with Veterans ages 60 and older who are experiencing pandemic-related emotional and physical distress. Methods and Procedures: Twenty-five older Veterans will be enrolled in this single-arm feasibility pilot trial. The intervention will be delivered weekly in 90-minute sessions of groups of four to five Veterans. Feasibility and acceptability of study procedures will be measured by referred-to-enrolled rate, telehealth access and capability, electronic data collection of outcome measures, and qualitative feedback on data collection procedures and measures. Feasibility and acceptability of the intervention will be measured by attendance; attrition; homework completion; participant ratings of the intervention's feasibility, acceptability, and fit; qualitative feedback; and treatment fidelity. Preliminary responsiveness of outcomes measures will be explored. Participants will complete measures of pandemic-related emotional and physical distress, psychological flexibility, depression, anxiety, social connectedness, perceived health, functional impairment, and meaningful engagement at baseline, posttreatment, and one-month follow-up. A brief midpoint assessment at week 5 of the group will consist of measures of social connectedness and functional impairment. Qualitative data will be gathered on perceived efficacy to implement intervention skills and specific emotional or behavioral changes participants have noticed in themselves as a result of the intervention. Conclusion: The telehealth Pan-ACT Group is a mental and behavioral health rehabilitation intervention that focuses on helping older Veterans develop or recover coping skills that were lost or are no longer effective during the ongoing COVID-19 pandemic. The proposed study address a major research and clinical gap by gathering new knowledge for an urgent need, which will inform the development of a full-scale randomized controlled trial to evaluate the intervention's effectiveness.

Interventions

BEHAVIORALPandemic Acceptance and Commitment Therapy (Pan-ACT)

Pan-ACT is a 10-session, closed group, transdiagnostic intervention for older adults delivered by telehealth platform.

Sponsors

VA Office of Research and Development
Lead SponsorFED
University of Alabama, Tuscaloosa
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Veteran * receives care at Tuscaloosa VA Medical Center * score of 9 or greater on the COVID-19 Mental Health Impacts Scale * English speaking * provides written informed consent * age 60 or older

Exclusion criteria

* diagnosis of dementia * score of 31 or less on the Modified Telephone Interview for Cognitive Status * actively suicidal or homicidal * actively psychotic * unstable medical condition * active substance use disorder * currently participating in another cognitive behavioral therapy (CBT) intervention

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of Study Protocol - Retention14 weeksRetention is defined as number of participants who completed the post-treatment endpoint assessment (numerator) divided by the number of participants who signed informed consent (enrolled; denominator).
Feasibility of Study Protocol - Telehealth Capability14 weeksPercent of participants enrolled (i.e., signed consent) who have telehealth capability for duration of intervention.
Acceptability of Intervention - Group Attendance14 weeksPercent of participants who started the Pan-ACT intervention (denominator) and attended 70% or more of intervention sessions (numerator)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLori L Davis, MD

Tuscaloosa VA Medical Center, Tuscaloosa, AL

Participant flow

Recruitment details

Participants were recruited from the Tuscaloosa VA Medical Center located in Tuscaloosa, Alabama (AL). Participants were enrolled between December 20, 2022, and May 22, 2024.

Pre-assignment details

There were no requirements for a treatment wash out or run-in period prior to being enrolled in the group intervention.

Baseline characteristics

Characteristic
Age, Continuous67.29 years
STANDARD_DEVIATION 3.56
COVID-19 Mental Health Impacts Scale11.8 units on a scale
STANDARD_DEVIATION 3.76
Race/Ethnicity, Customized
Black
17 Participants
Race/Ethnicity, Customized
White
7 Participants
Region of Enrollment
United States
24 Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
22 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 15
other
Total, other adverse events
0 / 15
serious
Total, serious adverse events
0 / 15

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026